Export 2703 results:
Author Title [ Type(Desc)] Year
Journal Article
S. P. Lerner, Bajorin, D. F., Dinney, C. P., Efstathiou, J. A., Groshen, S., Hahn, N. M., Hansel, D., Kwiatkowski, D., O'Donnell, M., Rosenberg, J., Svatek, R., Abrams, J. S., Al-Ahmadie, H., Apolo, A. B., Bellmunt, J., Callahan, M., Cha, E. K., Drake, C., Jarow, J., Kamat, A., Kim, W., Knowles, M., Mann, B., Marchionni, L., McConkey, D., McShane, L., Ramirez, N., Sharabi, A., Sharpe, A. H., Solit, D., Tangen, C. M., Amiri, A. Tawab, Van Allen, E., West, P. J., Witjes, J. A., and Quale, D. Zipursky, Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer., Bladder Cancer, vol. 2, no. 2, pp. 165-202, 2016.
E. Chew, Lindblad, A., Clemons, T., and Group, A. - R. Eye Diseas, Summary Results and Recommendations from the Age-Related Eye Disease Study, Arch Ophthalmol, vol. 127, pp. 1678-1679, 2009.
E. Y. Chew, Lindblad, A. S., and Clemons, T., Summary results and recommendations from the age-related eye disease study., Arch Ophthalmol, vol. 127, no. 12, pp. 1678-9, 2009.
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes., Pediatrics, vol. 105, no. 2, pp. 295-310, 2000.
T. S. T. O. P. - R. O. P. M. Group, Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial 1: Primary outcomes, Pediatrics, vol. 105, pp. 295-310, 2000.
J. Harbell, Fung, J., Nissen, N., Olthoff, K., Florman, S. S., Hanto, D. W., Light, J., Bartlett, S. T., Tzakis, A. G., Pearson, T. C., Barin, B., Roland, M. E., and Stock, P. G., Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients., Surgery, vol. 152, no. 3, pp. 376-81, 2012.
J. Harbell, Fung, J., Nissen, N., Olthoff, K., Florman, S., Hanto, D., Light, J., Bartlett, S., Tzakis, A., Pearson, T., Barin, B., Roland, M., and Stock, P., Surgical Complications in 275 HIV-Infected Liver and/or Kidney Transplantation Recipients, Surgery, vol. 152, pp. 376-381, 2012.
A. S. Lindblad, Nolph, K. D., Novak, J. W., and Friedman, E. A., A survey of the NIH CAPD Registry population with end-stage renal disease attributed to diabetic nephropathy., J Diabet Complications, vol. 2, no. 4, pp. 227-32, 1988.
H. O. Douglass, Moertel, C. G., Mayer, R. J., Thomas, P. R., Lindblad, A. S., Mittleman, A., Stablein, D. M., and Bruckner, H. W., Survival after postoperative combination treatment of rectal cancer., N Engl J Med, vol. 315, no. 20, pp. 1294-5, 1986.
D. M. Stablein, Carter, W. H., and Wampler, G. L., Survival analysis of drug combinations using a hazards model with time-dependent covariates., Biometrics, vol. 36, no. 3, pp. 537-46, 1980.
M. E. Roland, Barin, B., Huprikar, S., Murphy, B., Hanto, D. W., Blumberg, E., Olthoff, K., Simon, D., Hardy, W. D., Beatty, G., and Stock, P. G., Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls., AIDS, vol. 30, no. 3, pp. 435-44, 2016.
A. Girach, Aiello, L. P., Milton, R. C., Davis, M. D., Danis, R. P., Zhi, X., Sheetz, M. J., and Vignati, L., Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy., Eye (Lond), vol. 23, no. 1, pp. 209-14, 2009.
A. Girach, Aiello, L., Milton, R., Davis, M., Danis, R., Zhi, X., Sheetz, M., Vignati, L., and Group, P. K. C. - D. R. S. 2Study, Sustained Moderate Visual Loss as a Predictive End Point for Visual Loss in Non-Proliferative Diabetic Retinopathy, Eye (Lond), vol. 23, pp. 209-214, 2009.
M. Eydelman, Hilmantel, G., Tarver, M. E., Hofmeister, E. M., May, J., Hammel, K., Hays, R. D., and Ferris, F., Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies., JAMA Ophthalmol, vol. 135, no. 1, pp. 13-22, 2017.
I. Hand, Boron, M., and Van Veldhuisen, P., Synagisâ (Palivizumab) prophylaxis of respiratory syncytial virus (RSV) infection - patient demographics and preliminary results from the 2000-2001 SynagisÒ Outcomes Registry, 2001.
M. Hudak, Chartrand, S., and Registry, S. Outcomes, Synagis® (Palivizumab) Prophylaxis of Respiratory Syncytial Virus (RSV) Infection - Patient Dempgraphics and Preliminary Results from 2000-2001 Synagis® Outcomes Registry, J Perinatology, vol. 21, pp. 500-501, 2001.
M. S. Natrajan, Rouphael, N., Lai, L., Kazmin, D., Jensen, T. L., Weiss, D. S., Ibegbu, C., Sztein, M. B., Hooper, W. F., Hill, H., Anderson, E. J., Johnson, R., Sanz, P., Pulendran, B., Goll, J. B., and Mulligan, M. J., Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses., Vaccines (Basel), vol. 8, no. 1, 2019.
I. Tellez, Sabbaj, S., Peng, X., Mulligan, M. J., and AVEG], theN. I. H. A. I. D. S. V., T cell and antibody responses in HIV-1 seronegative volunteers immunized with recombinant canarypox and gp120 prime-boost vaccines, 1999.
S. M. Bartosh and Stablein, D. M., Tacrolimus as primary immunosuppression for children receiving non-primary renal transplants: A report of the North American Pediatric Cooperative Study (NAPRTCS), 2000.
A. Krupnick, Serle, J., Van Veldhuisen, P., Lind, L., Clarke, J., Singer, G., and Lebwohl, M., Tacrolimus ointment for the treatment of eyelid dermatitis, Cutis, vol. 73, pp. 267-71, 2004.
A. Krupnick Freeman, Linowski, G. J., Brady, C., Lind, L., VanVeldhuisen, P., Singer, G., and Lebwohl, M., Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas., J Am Acad Dermatol, vol. 48, no. 4, pp. 564-8, 2003.
A. K. Freeman, Linowski, G. C., Brady, C., Lind, L., Van Veldhuisen, P., Singer, G., and Lebwohl, M., Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas, J Amer Acad Dermatology, vol. 48, pp. 564-8, 2003.
M. Lebwohl, Freeman, A. Krupnick, M Chapman, S., Feldman, S. R., Hartle, J. E., and Henning, A., Tacrolimus ointment is effective for facial and intertriginous psoriasis., J Am Acad Dermatol, vol. 51, no. 5, pp. 723-30, 2004.
M. Lebwohl, Freeman, A. K., Chapman, M. S., ,, J Hartle, M. P. H., Henning, A. K., and Group, T. Ointment S., Tacrolimus Ointment is Effective for Facial and Intertriginous Psoriasis, Journal of the American Academy of Dermatology, vol. 51, pp. 723-30, 2004.
G. W. Burke, Kaufman, D. B., Bruce, D. S., Sutherland, D., Johnson, C. P., Gaber, A. O., Merion, R. M., Schweitzer, E., Marsh, C. L., Gruber, S. A., Alfrey, E., Leone, J. P., Conception, W., Stegall, M. D., Gores, P. S., Danovitch, G., Nunnally, P. J., Henning, A. K., and Fitzsimmons, W. E., Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) +/- antibody induction in simultaneous pancreas kidney (SPK) transplantation: one year results, 2001.